A trial looking at treatments for different types of bowel cancer (FOCUS4)

Overview

Cancer types:

Bowel (colorectal) cancer, Colon cancer, Rectal cancer

Status:

Results

Phase:

Phase 2/3

Details

This trial looked at different treatments for certain types of bowel cancer. It was for people with bowel cancer that couldn’t be removed with surgery or had spread to another part of the body.

The trial was open for people to join between 2014 and 2020. The team have published several results papers in different medical journals.

Recruitment start: 10 January 2014

Recruitment end: 9 July 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Maughan Professor Richard Wilson

Supported by

AstraZeneca

Bayer

Cancer Research UK

Cardiff University

Medical Research Council (MRC)

NIHR Clinical Research Network: Cancer

NIHR Efficacy and Mechanism Evaluation (EME) Programme

University College London (UCL)

University of Belfast

University of Leeds

University of Oxford

Other information

The Trial was jointly funded by Cancer Research UK and the Medical Research Council (MRC)/National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (EME) Programme.

This is Cancer Research UK trial number CRUK/11/054.

Last reviewed: 24 April 2023

CRUK internal database number: 9181